Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Allergy & Immunology
•
Asthma
Which biologics for asthma have data regarding mucus plugging?
Related Questions
Are there best practices for integrating pollen, wildfire smoke, and AQI data into asthma/allergic rhinitis action plans?
If a child 4 years of age or younger has respiratory symptoms consistent with asthma, are you diagnosing asthma or using different terminology such as bronchiolitis or reactive airway disease?
Should thunderstorm asthma be incorporated into asthma action plans?
Should a patient on medium-dose ICS/LABA with normal PFTs, but who shows a greater than 10% decrease in FEV1 if their PFTs are done after 24 hours off their inhaler, be started on a biologic?
Do you generally favor nebulizers, HFAs or other devices in children aged 5 and younger with asthma?
Do you withhold performing skin testing for aeroallergens, foods or venoms based on poor lung function?
Do you plan to use benralizumab to treat acute exacerbations of asthma or COPD associated with eosinophilia?
Is there any genetic testing available for the CDHR3 receptor?
Would you stop Dupixent in an asthma patient who has good asthma control and notes improvement in loss of smell, but shows notable eosinophil elevation after 4-5 doses of the medication?
Is there a specific group of children that you start on AIT for prevention of asthma?
